Related Experiment Video
Updated: Feb 25, 2026

Fluorescence Assays for the Study of Mycobacterium tuberculosis Interaction with the Immune Receptor SLAMF1
Published on: February 28, 2025
Alveolar macrophages shape tuberculosis susceptibility by delaying protective immunity
Consuelo Micheli1, Ana Rita Oliveira1, Beatriz Millan1
1Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal; ICVS/3B's - PT Government Associate Laboratory, Braga/Guimarães, Portugal.
Alveolar macrophages (AMs) in tuberculosis delay CD4+ T cell priming by trapping Mycobacterium tuberculosis (Mtb). Sequential targeting of AMs and neutrophils improves adaptive immunity and infection control.
Area of Science:
- Immunology
- Microbiology
- Infectious Diseases
Background:
- Effective control of Mycobacterium tuberculosis (Mtb) infection depends on CD4+ T cell responses in the lungs.
- Factors contributing to delayed T cell activation in tuberculosis remain incompletely understood.
Purpose of the Study:
- To investigate the role of alveolar macrophages (AMs) in delaying CD4+ T cell priming during Mtb infection.
- To explore therapeutic strategies involving AMs and neutrophils for improved tuberculosis control.
Main Methods:
- Utilized mouse models (C3HeB/FeJ and C57BL/6) to study Mtb infection dynamics.
- Assessed the impact of AMs and neutrophils on T cell responses and bacterial load.
- Investigated the role of IL-1β and GM-CSF in AM function and migration.
Main Results:
- Alveolar macrophages (AMs) retain Mtb, limiting myeloid cell access and delaying CD4+ T cell priming.
- Reduced IL-1β and GM-CSF in susceptible mice impair AM migration.
- Targeting AMs accelerates adaptive immunity but is insufficient for chronic control due to neutrophil interference.
- Sequential depletion of AMs and neutrophils restores CD4+ T cell function and enhances infection control.
Conclusions:
- Alveolar macrophages represent a novel bottleneck in initiating adaptive immunity against Mtb.
- Targeting AMs can accelerate immune responses but requires concurrent management of neutrophil-mediated inflammation for sustained tuberculosis control.
Related Concept Videos
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:

